Patents Assigned to Georgetown University
  • Patent number: 12759980
    Abstract: Provided herein are compositions and methods for treating or preventing a neurodegenerative disease, a neurodevelopmental disease, a myodegenerative disease, a prion disease, a lysosomal storage disease or cancer in a subject.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: October 13, 2026
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Charbel Moussa, Christian Wolf, Balaraman Kaluvu
  • Patent number: 12749609
    Abstract: Embodiments may provide the realization of strong Dzyaloshinskii-Moriya Interaction (DMI) and perpendicular magnetic anisotropy (PMA) induced by chemisorbed species on a ferromagnetic layer. For example, in an embodiment, an apparatus for generating a Dzyaloshinskii-Moriya interaction may comprise a ferromagnet comprising a single layer or multi-layers of materials made of metal, oxide or other types of magnetic films, and a substance chemisorbed on a surface of the ferromagnet to induce the Dzyaloshinskii-Moriya interaction or the perpendicular magnetic anisotropy at the interface between chemisorbed species and ferromagnet. These induced effects may be used to manipulate spin textures such as switching of domain wall chirality and writing/deleting of magnetic skyrmions, which are relevant for spintronics, magneto-ionics as well as gas sensing.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: September 29, 2026
    Assignees: Georgetown University, The Regents of the University of California
    Inventors: Gong Chen, Kai Liu, Andreas Schmid
  • Patent number: 12749330
    Abstract: Technologies are described for reconstructing physical objects which are preserved or represented in pictorial records. The reconstructed models can be three-dimensional (3D) point clouds and can be compared to existing physical models and/or other reconstructed models based on physical geometry. The 3D point cloud models can be encoded into one or more latent space feature vector representations which can allow both local and global geometric properties of the object to be described. The one or more feature vector representations of the object can be used individually or in combination with other descriptors for retrieval and classification tasks. Neural networks can be used in the encoding of the one or more feature vector representations.
    Type: Grant
    Filed: July 18, 2024
    Date of Patent: September 29, 2026
    Assignee: Georgetown University
    Inventors: Cristopher Flagg, Ophir Frieder
  • Publication number: 20260286302
    Abstract: A unique CD8 T cell central memory subtype obtained by treatment of CD8 T cells with a poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) is described. These cells, referred to as super-central memory CD8 T cells (TCMsup) or PARPi-induced memory T cells, are significantly more efficient for cancer therapy than traditional central memory T cells (TCM) generated by tumor antigens. Methods of using the TCMsup cells for enhancing cancer immunotherapy, enhancing vaccine-induced immunity, and treating cancer are described.
    Type: Application
    Filed: April 12, 2024
    Publication date: September 24, 2026
    Applicant: Georgetown University
    Inventors: Samir N. Khleif, Seema Gupta, Wael Traboulsi
  • Patent number: 12744030
    Abstract: Embodiments of the present systems and methods may provide techniques for synthesizing speech in any voice in any language in any accent. For example, in an embodiment, a text-to-speech conversion system may comprise a text converter adapted to convert input text to at least one phoneme selected from a plurality of phonemes stored in memory, a machine-learning model storing voice patterns for a plurality of individuals and adapted to receive the at least one phoneme and an identity of a speaker and to generate acoustic features for each phoneme, and a decoder adapted to receive the generated acoustic features and to generate a speech signal simulating a voice of the identified speaker in a language.
    Type: Grant
    Filed: May 28, 2024
    Date of Patent: September 22, 2026
    Assignee: Georgetown University
    Inventors: Joe Garman, Ophir Frieder
  • Patent number: 12742200
    Abstract: Provided are methods and compositions useful for assessing the length of telomeres. The disclosed methods and compositions are amenable to performance as a high-throughput method to assess telomere length (TL) and TL constitution using genomic DNA. Also provided are methods for diagnosing a telomere-related condition or disease in a subject, assessing general health and/or aging of a subject, establishing a relationship between telomere constitution and cancer and/or aging-related disease, assessing exposure to harmful substances and/or stresses of a subject, assessing response to a drug or drugs treatment of a subject, assessing disease risk of a subject, and assessing clinical outcome of a subject who is suffering from a disease/diseases. The methods are useful in studies of individuals and populations.
    Type: Grant
    Filed: July 30, 2020
    Date of Patent: September 22, 2026
    Assignee: Georgetown University
    Inventor: Yun-Ling Zheng
  • Patent number: 12724014
    Abstract: The present application relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, providing certain probes; and providing an indicator. The sample is contacted with an excess of the probe under conditions to permit irreversible covalent binding of the probe to the analyte, if present in the sample. The sample is contacted with the indicator under conditions to permit covalent binding of the indicator to any excess probe that is not bound to the analyte. Based on any binding that occurs between the analyte and probe, the absolute configuration of the analyte in the sample and/or the enantiomeric composition of the analyte in the sample using a chiroptical technique is/are determined. Based on any binding that occurs between the indicator and probe, the concentration of the analyte in the sample is determined using a non-chiroptical technique.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: September 1, 2026
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Christian Wolf, Yushra F. Thanzeel, Balaraman Kaluvu
  • Patent number: 12711408
    Abstract: A hypotheses generation and event recognition system that enables event recognition by analyzing documents to construct one or more qualitative metrics (e.g., frequency of keywords, changes in sentiment, occurrence of ontological terms, evolution of topics, etc.), establishing a baseline for the qualitative metric(s), and outputting changes to that baseline for display. In aggregate, those qualitative metrics comprise temporal and/or spatial signals that, when combined, define signatures of events of interest. Accordingly, the user and/or the system may identify an event of interest based on the change in baseline. The system may further provide functionality to generate hypotheses by coding data according to an ontology, populating an ontology space, and using an optimization algorithm to rank points or neighborhoods in the coded ontology space.
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: August 18, 2026
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: David M. Hartley, Nili S. Yossinger, Ophir Frieder
  • Patent number: 12690782
    Abstract: A gait analysis system, which includes a neural network with a recurrent neural network layer and a fully connected layer, that receives sensor data indicative of an individual's gait and outputs an assessment regarding the individual's health. The neural network is trained using training data indicative of abnormal gaits and normal gaits. To analyze the training data and the sensor data, the recurrent neural network layer parses each piece of data into a series of windows and analyzes each window in series to generate a context vector characterizing each window and the previously analyzed windows. The fully connected layer, having been trained to differentiate between normal gaits and abnormal gaits based on context vectors characterizing the training data, is used to generate a final assessment characterizing the user gate as normal or abnormal using one or more of the context vectors characterizing the sensor data.
    Type: Grant
    Filed: January 26, 2023
    Date of Patent: July 28, 2026
    Assignee: Georgetown University
    Inventors: Gholam Motamedi, Ophir Frieder, Cristopher Flagg, Jian-Young Wu
  • Patent number: 12694956
    Abstract: A method and system for merging healthcare records across multiple locations is presented. The method first creates anonymized healthcare records by removing personally identifiable information. The method then converts each record into an embedding and appends a site locator identifying only the originator of the healthcare record. Then these embeddings are combined with similarly processed embeddings from multiple sites to create a merged database of embeddings derived from patient healthcare records. A classifier is trained to predict likely outcomes based on the merged database of embeddings. For a new patient, the corresponding healthcare record is converted to an embedding and the merged database of embeddings is then searched for a most similar patient and a treatment is recommended for the new patient, based on the prediction of the classifier.
    Type: Grant
    Filed: May 3, 2023
    Date of Patent: July 28, 2026
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Ophir Frieder, Dinesh Maheshwari
  • Patent number: 12685757
    Abstract: Provided herein are methods of stabilizing blood pressure in severe sepsis/septic shock and other types of distributive shock using TRPV1 agonists. Also provided are pharmaceutical formulations for increasing blood pressure in septic shock the formulation including at least one TRPV1 agonist in a dosage form for parenteral administration, wherein the TRPV1 agonist is selected from capsaicin, daphnane TRPV1 agonists, vanillotoxin, N-oleoyl dopamine, N-arachidonyl dopamine, BrP-LPA, and derivatives and analogues thereof. Also provided are TRPV1 agonists co-lyophilized with adrenergic agonists and/or angiotensins in a dosage form for reconstitution and parenteral administration.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: July 21, 2026
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Gerard P. Ahern, Thieu X. Phan
  • Patent number: 12678425
    Abstract: A combinatorial method for treating against, or at least inhibiting or suppressing, the proliferation of an internal ribosome entry site utilizing virus (IRES-utilizing virus) in a host in need of treatment involves administering the host a compound, a tautomer, or a pharmaceutically acceptable salt thereof, in an amount effective for inhibiting replication of the IRES-utilizing virus in cells, wherein the compound is represented by the formula: wherein each R1 is independent of the other and represents a halogen atom selected from the group consisting of bromo, chloro, fluoro and iodo; and either separately administering another anti-viral drug and/or pro-drug to the anti-viral drug or co-administering the anti-viral drug and/or the pro-drug with the compound, its tautomer, or its pharmaceutically acceptable salt.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: July 14, 2026
    Assignees: Howard University, GEORGETOWN UNIVERSITY
    Inventors: Hemayet Ullah, Sivanesan Dakshanamurthy
  • Publication number: 20260191880
    Abstract: Provided herein are methods for treating a cholecystokinin (CCK) receptor-expressing cancerous tumor in a subject. Also provided are methods for increasing sensitivity of a (CCK) receptor-expressing cancerous tumor in a subject to immunotherapy.
    Type: Application
    Filed: January 17, 2025
    Publication date: July 9, 2026
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Jill P. SMITH, Louis WEINER, Sandra JABLONSKI, Sandeep NADELLA, Shangzi WANG
  • Publication number: 20260167715
    Abstract: Provided herein are methods of targeting PD-1+CD38hiCD8+ T cells to reduce apoptosis of white blood cells (e.g., lymphocytes). Further provided are methods of inducing apoptosis of white blood cells in a subject by using adoptive cell therapy with PD-1+CD38hiCD8+ T cells.
    Type: Application
    Filed: October 26, 2023
    Publication date: June 18, 2026
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Pankaj N. GAUR, Samir KHLEIF, Seema GUPTA, Vivek VERMA
  • Publication number: 20260147126
    Abstract: A method is provided to reduce the counting times in radiation detection systems using machine learning, wherein the method comprises: receiving output data from a detector which is to detect a target material from a target body; analyzing the output data; identifying a material of interest from the analyzed output data; and controlling a source of the target material to prevent the source from harming the target body. An apparatus is also provided which comprises: a detector to detect radiation and to provide an output data in real-time; and a processor coupled to the detector, wherein the processor is to: receive the output data; analyze the output data; identify a material of interest from the analyzed output data; and control a source of the target material.
    Type: Application
    Filed: April 14, 2025
    Publication date: May 28, 2026
    Applicants: Oregon State University, Georgetown University
    Inventors: Ophir Frieder, Steven Richard Reese, Jessica Ryan Curtis
  • Patent number: 12629355
    Abstract: A method for treating against, or at least inhibiting or suppressing, the proliferation of a cancer involves administering a compound, a tautomer, or a pharmaceutically acceptable salt thereof, in an amount effective for inhibiting metastasis of cancer cells, wherein the compound is represented by the formula (1): wherein each R1 independent of the other and represents a halogen atom selected from the group consisting of bromo, chloro, fluoro and iodo.
    Type: Grant
    Filed: March 25, 2020
    Date of Patent: May 19, 2026
    Assignees: Howard University, GEORGETOWN UNIVERSITY
    Inventors: Hemayet Ullah, Sivanesan Dakshanamurthy
  • Patent number: 12619934
    Abstract: A specialized computing environment that includes hardware and data security features to enable competitive organizations to co-analyze proprietary data without revealing the underlying proprietary data to unauthorized users. Proprietary data are stored in volatile memory, which may be automatically erased according to pre-stored criteria. The analysis is performed automatically by a processing unit without human intervention. Analytical results are sanitized (e.g., using data masking) to prevent the analytical result from being tracible to any particular data source. Sanitized analytical results are output without outputting the underlying proprietary data (except to users authorized to validate analytical results). The computing environment is enclosed within a secure enclosure (e.g.
    Type: Grant
    Filed: May 9, 2023
    Date of Patent: May 5, 2026
    Assignee: Georgetown University
    Inventors: David Hartley, Ophir Frieder
  • Publication number: 20260083724
    Abstract: Compounds comprising a PAX3::FOXO1 fusion protein binding moiety, a bivalent linker, and an E3 ubiquitin ligase binding moiety. The compounds can be used to reduce PAX3::FOXO1 protein levels in a subject with fusion-positive rhabdomyosarcoma (FP-RMS), to ubiquitinate a PAX3::FOXO1 fusion protein in a cell, to treat FP-RMS in a subject in need thereof, and/or to treat a disease caused by the overexpression of PAX3::FOXO1 protein in a subject in need thereof.
    Type: Application
    Filed: September 26, 2025
    Publication date: March 26, 2026
    Applicant: Georgetown University
    Inventors: Aykut Üren, Jeffrey A. Toretsky
  • Patent number: 12521659
    Abstract: A metal foam-based filtration system and method for removing sub-micron particles and contaminants from a gas or fluid flow with the use of ultralow density metal nanowire meshes that have nanometer to micron scale pores for trapping air/fluid-borne particulates. Filters can use metal foams and coated metal foams alone or in tandem. The size and density of pores in the foam can be adjusted with synthesis conditions. Foams with pore size gradients promote the trapping of different sized particulates at different regions of a foam. Multiple rounds of electrodeposition may be applied to increase the surface area and curvature of a nanowire mesh and strengthen the mesh to make it self-supporting, free-standing and capable of supporting a much heavier mass without collapse. A metal and/or a coated metal foam can act as a catalyst or substrate for absorption or adsorption to capture target particles and/or contaminants.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: January 13, 2026
    Assignee: Georgetown University
    Inventors: Kai Liu, James D. Malloy
  • Patent number: 12517111
    Abstract: Systems and methods for characterizing cancer cells are disclosed. In certain embodiments, the systems and methods involve coating a first chamber with ECM material and adding a first plurality of cells to the first chamber, adding media to a second chamber, and adding a second plurality of cells and media to a third chamber. The first, second, and third chambers are then clipped together to form a chamber array. The chamber array is mounted to an electric cell impedance sensing reader and impedance readouts of cell invasion are collected from the electric array at time intervals. Cells detected to invade into the second chamber are extracted and characterized.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: January 6, 2026
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Anton Wellstein, Ghada M. Sharif, Makarand Paranjape, Leon Der